Pfizer Inc patents expiration
1. Camptosar patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6403569 | PFIZER INC | Method for treating cancer using camptothecin derivatives and 5-fluorouracil |
Apr, 2020
(4 years ago) | |
| US6794370 | PFIZER INC | Method for treating cancer using camptothecin derivatives and 5-fluorouracil |
May, 2020
(4 years ago) | |
|
US6403569 (Pediatric) | PFIZER INC | Method for treating cancer using camptothecin derivatives and 5-fluorouracil |
Oct, 2020
(3 years ago) | |
|
US6794370 (Pediatric) | PFIZER INC | Method for treating cancer using camptothecin derivatives and 5-fluorouracil |
Nov, 2020
(3 years ago) | |
Drugs and Companies using IRINOTECAN HYDROCHLORIDE ingredient
Market Authorisation Date: 14 June, 1996
Treatment: Use in combination with 5-fluorouracil and leucovorin for the treatment of metastatic colorectal cancer where the dose of leucovorin is at least 200mg per square meter; Use of irinotecan in combinatio...
Dosage: INJECTABLE;INJECTION
CAMPTOSAR family patents
2. Geodon patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5312925 | PFIZER INC | Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride |
Sep, 2012
(11 years ago) | |
| US6245766 | PFIZER INC | Method of treating psychiatric conditions |
Dec, 2018
(5 years ago) | |
| US6150366 | PFIZER INC | Ziprasidone formulations |
May, 2019
(4 years ago) | |
| US7175855 | PFIZER INC | Ziprasidone suspension |
May, 2020
(3 years ago) | |
Drugs and Companies using ZIPRASIDONE HYDROCHLORIDE ingredient
Market Authorisation Date: 29 March, 2006
Treatment: Treatment of neuroleptic diseases; Treatment of bipolar disorder; Treatment of psychosis
Dosage: SUSPENSION;ORAL
GEODON family patents
3. Nicotrol patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5656255 | PFIZER INC | Composition to help stop smoking |
Aug, 2014
(9 years ago) | |
Drugs and Companies using NICOTINE ingredient
Market Authorisation Date: 22 March, 1996
Treatment: NA
Dosage: SPRAY, METERED;NASAL
NICOTROL family patents